Catherine Pickering is the founder of iOnctura. iOnctura has raised $130M in total funding. Latest round: Series B. Based in Geneva, Switzerland.
Catherine Pickering is the Co-Founder and CEO of iOnctura, a clinical-stage biopharmaceutical company based in Geneva, Switzerland, focused on combating neglected and hard-to-treat cancers. She founded the company in 2017 after securing over €2M in seed funding from Merck for her initial idea. Pickering has led iOnctura through multiple funding stages, including Seed, Series A, and Series B, raising nearly $130M in total financing to advance two lead clinical programs toward Phase II studies.
Full founder directory · Investor directory · Company funding database · Fundraising library